MALIGNANT MELANOMA OF SITES OTHER THAN SKIN

MALIGNANT MELANOMA OF SITES OTHER THAN SKIN was reported 51 times

These drug classes are most commonly taken by patients reporting MALIGNANT MELANOMA OF SITES OTHER THAN SKIN:

# Drug Count
0 Tumor Necrosis Factor Blocker [EPC] 11
1 Corticosteroid [EPC] 8
2 Integrin Receptor Antagonist [EPC] 5
3 Interferon beta [EPC] 4
4 Kinase Inhibitor [EPC] 4
5 Benzodiazepine [EPC] 3
6 Nonsteroidal Anti-inflammatory Drug [EPC] 3
7 Proton Pump Inhibitor [EPC] 3
8 beta-Adrenergic Blocker [EPC] 3
9 Alkylating Drug [EPC] 2
10 Factor Xa Inhibitor [EPC] 2
11 Loop Diuretic [EPC] 2
12 Platelet Aggregation Inhibitor [EPC] 2
13 Platinum-based Drug [EPC] 2
14 Purine Antimetabolite [EPC] 2
15 Vitamin C [EPC] 2
16 alpha-Adrenergic Blocker [EPC] 2
17 Aldosterone Antagonist [EPC] 1
18 Alkaloid [EPC] 1
19 Aluminum Complex [EPC] 1
20 Aminosalicylate [EPC] 1
21 Antimycobacterial [EPC] 1
22 Bile Acid [EPC] 1
23 CD20-directed Cytolytic Antibody [EPC] 1
24 Calcineurin Inhibitor Immunosuppressant [EPC] 1
25 Dietary Cholesterol Absorption Inhibitor [EPC] 1
26 Dihydropyridine Calcium Channel Blocker [EPC] 1
27 Endothelin Receptor Antagonist [EPC] 1
28 Estrogen Agonist/Antagonist [EPC] 1
29 Estrogen [EPC] 1
30 Folate Analog Metabolic Inhibitor [EPC] 1
31 HMG-CoA Reductase Inhibitor [EPC] 1
32 Influenza A M2 Protein Inhibitor [EPC] 1
33 Interleukin-23 Antagonist [EPC] 1
34 Interleukin-5 Antagonist [EPC] 1
35 Interleukin-6 Receptor Antagonist [EPC] 1
36 Nitrate Vasodilator [EPC] 1
37 Nucleoside Metabolic Inhibitor [EPC] 1
38 Phosphodiesterase 5 Inhibitor [EPC] 1
39 Programmed Death Receptor-1 Blocking Antibody [EPC] 1
40 Prostacyclin Receptor Agonist [EPC] 1
41 Rifamycin Antibacterial [EPC] 1
42 Serotonin Reuptake Inhibitor [EPC] 1
43 Serotonin-3 Receptor Antagonist [EPC] 1
44 Thiazide-like Diuretic [EPC] 1
45 Topoisomerase Inhibitor [EPC] 1
46 Vascular Endothelial Growth Factor Inhibitor [EPC] 1
47 Vitamin B12 [EPC] 1
48 Vitamin D [EPC] 1
49 alpha-Glucosidase Inhibitor [EPC] 1